March 18, 2021 Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287
March 18, 2021 Considerations for Participation in PPP Projects: Learnings from the Critical Path for Parkinson’s Consortium, D. Stephenson Session: # S0802-L, Understanding of Different Set Ups of PPP, Benefits of PPPs and Learnings of Recent Projects to Facilitate
November 13, 2020 C-Path’s PKDOC Presentation on Fluid-Based Biomarkers Critical Path Institute’s John-Michael Sauer, Ph.D. presents information on fluid-based biomarkers and how they can be applied
October 9, 2020 Webinar: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis (Sept.18, 2020)
October 9, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute